|

Recombinant Thyrotropin Alfa Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Recombinant TSH Alpha, Recombinant Thyrotropin Alpha, TSH-alpha, Thyrogen, Thyroid Stimulating Hormone Alpha +1 more

Pipeline

Phase 2: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Thyroid Gland Papillary Carcinoma1
  • Thyroid Gland Oncocytic Carcinoma1
  • Thyroid Gland Follicular Carcinoma1
  • Cancer1

Duarte, California1 trial

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

City of Hope Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.